Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02717624
Title A Study of ACP-196 in Combination With Bendamustine and Rituximab in Subjects With Mantle Cell Lymphoma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Acerta Pharma BV

mantle cell lymphoma


Acalabrutinib + Bendamustine + Rituximab

Age Groups: adult
Covered Countries USA | ITA

No variant requirements are available.